Bristol Myers Squibb Myeloma Trials
Hi, we're SparkCures. We've partnered with Bristol Myers Squibb to help myeloma patients find and connect with clinical trials from around the US.
Featured Clinical Trials
Learn more about the Quintessential trial for patients with relapsed/refractory multiple myeloma who have received 3 or more prior lines of therapy.
Learn more about the Successor-1 trial for patients with relapsed/refractory multiple myeloma who have received 1-3 prior lines of therapy.
Learn more about the Successor-2 trial for patients with relapsed/refractory multiple myeloma who have received one prior line of therapy.
Learn more about the Excaliber RRMM trial for patients with relapsed/refractory multiple myeloma who have received 1-2 prior lines of therapy.
Get Personalized Results
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Explore Trials by Centers
There are more than 180 centers around the US participating in BMS sponsored myeloma clinical trials. Use the links below to explore clinical trials by centers.
About Us
At SparkCures, we help patients and healthcare professionals find, understand and connect with eligible clinical trials from around the US.
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Real People. Real Support.
We're real people, and we want to help! Connect with us today to explore your trial options and discuss questions you can ask your doctor as you prepare for your next appointment.